The academic editors of eLife, the new open-access journal for the very best in life sciences and biomedical research, have selected four published studies to represent the breadth, quality, and importance of papers invited by the journal. Pre-tenure authors on the papers will present at the scientific meetings of eLife’s prestigious founding organisations: the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust.
eLife Sciences is a unique collaboration between the funders and practitioners of research to enhance the communication of influential discoveries through open access, digital media, and fast, fair, and constructive review. eLife is committed to creating a positive publishing experience, particularly for early-career investigators for whom delays and punishing reviews are most costly.
Selected papers were published before May 28, 2013, cover a range of subjects, and have advanced our understanding of the influenza and hepatitis viruses, the evolution of animal cells, and the techniques we use to determine the structure of proteins. They include:
Stability-mediated epistasis constrains the evolution of an influenza protein
Lizhi Ian Gong, Marc A Suchard, Jesse D Bloom
Ribosome structures to near-atomic resolution from thirty thousand cryo-EM particles
Xiao-chen Bai, Israel S Fernandez, Greg McMullan, Sjors HW Scheres
A bacterial sulfonolipid triggers multicellular development in the closest living relatives of animals
Rosanna A Alegado, Laura W Brown, Shugeng Cao, Renee K Dermenjian, Richard Zuzow, Stephen R Fairclough, Jon Clardy, Nicole King
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan, Guocai Zhong, Guangwei Xu, Wenhui He, Zhiyi Jing, Zhenchao Gao, Yi Huang, Yonghe Qi, Bo Peng, Haimin Wang, Liran Fu, Mei Song, Pan Chen, Wenqing Gao, Bijie Ren, Yinyan Sun, Tao Cai, Xiaofeng Feng, Jianhua Sui, Wenhui Li
Authors Jesse Bloom, Wenhui Li, Rosanna Alegado, and Israel Sanchez will now be sponsored to present their work at their choice of meeting, hosted by one of eLife’s founding organisations.
“Congratulations Dr. Bloom, Dr. Li, Dr. Alegado, Dr. Sanchez, and your co-authors for having your work honoured by our colleagues in this way,” said Randy Schekman, the journal’s editor-in-chief. “You made the right choice trusting eLife with your best work.” Schekman is co-recipient of the 2013 Nobel Prize in Physiology or Medicine.
These sponsored presentations are just one element in eLife’s suite of initiatives to enhance the experience of publishing in a high-profile journal for early-career investigators. More details are described in today’s editorial, available at http://elife.elifesciences.org/content/2/e01633.
# # #
+44 (0) 1223 370155 (UK)
About eLife Sciences
eLife Sciences is a unique collaboration between the funders and practitioners of research to communicate ground-breaking discoveries in the life and biomedical sciences in the most effective way. The eLife journal is a platform for maximising the reach and influence of new discoveries and showcasing new approaches to the presentation, use, and assessment of research. As an open-access journal, eLife delivers access to content for free, online, immediately on publication, and will encourage maximum possible reach and utility of the content by publishing under the terms of the Creative Commons Attribution License, which is emerging as the gold standard for open-access publishing. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust. Learn more at elifesciences.org.